Gland Pharma Limited (GLAND) — Free Cash Flow Generation Index

Latest as of September 2025: 0.67x

Gland Pharma Limited (GLAND) has a Free Cash Flow Generation Index of 0.67x as of September 2025. Free cash flow of Rs3.99 Billion represents 1% of operating cash flow (Rs5.93 Billion). See how liquid is Gland Pharma Limited's working capital to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.67x
Free Cash Flow / Operating CF

Free Cash Flow

Rs3.99 Billion
INR

Operating Cash Flow

Rs5.93 Billion
INR

Capital Expenditures

Rs1.94 Billion
INR

Gland Pharma Limited Free Cash Flow Generation Index (2017–2025)

Historical FCF Generation Index trend for Gland Pharma Limited across 9 annual periods. Explore GLAND debt coverage from operations to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Gland Pharma Limited (2017–2025)

Year-by-year Free Cash Flow Generation Index for Gland Pharma Limited. For the full company profile including market capitalisation, see Gland Pharma Limited (GLAND) market capitalisation.

Year FCG Index Free Cash Flow (INR) Operating CF Capital Expenditures YoY Change
2025 0.58x Rs5.30 Billion Rs9.15 Billion Rs3.85 Billion ▼ -4.8%
2024 0.61x Rs6.07 Billion Rs9.97 Billion Rs3.90 Billion ▲ +57.3%
2023 0.39x Rs1.41 Billion Rs3.64 Billion Rs2.23 Billion ▲ +13.9%
2022 0.34x Rs2.69 Billion Rs7.91 Billion Rs5.22 Billion ▼ -45.4%
2021 0.62x Rs3.76 Billion Rs6.05 Billion Rs2.29 Billion ▼ -13.9%
2020 0.72x Rs5.06 Billion Rs7.01 Billion Rs1.95 Billion ▲ +170.3%
2019 0.27x Rs495.11 Million Rs1.85 Billion Rs1.36 Billion ▼ -53.8%
2018 0.58x Rs1.17 Billion Rs2.02 Billion Rs851.75 Million ▼ -23.5%
2017 0.76x Rs3.60 Billion Rs4.76 Billion Rs1.16 Billion
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).